Market Cap 3.41B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 3,810,854
Avg Vol 8,089,554
Day's Range N/A - N/A
Shares Out 306.61M
Stochastic %K 98%
Beta 1.20
Analysts Strong Sell
Price Target $16.12

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
snowPOW
snowPOW Aug. 20 at 5:52 PM
$BB what I'm watching in relation to this old news for the upcoming summit https://www.pm.gc.ca/en/news/news-releases/2026/04/17/prime-minister-carney-announces-first-ever-canada-investment-summit $TSAT and $ABCL too Obviously there's many more, but these are the ones on my radar.
0 · Reply
Bullock3000
Bullock3000 Aug. 20 at 5:18 PM
$ABCL Cute chart, saw it onn X last night. What the chart doesn't address is immunogenicity. For BLA products, our bodies form new antibodies to destroy the BLA product. Each dose of the BLA adds immunogenicity. That's why the duration of efficacy for a BLA is months, not years, as in small molecules.
1 · Reply
daytwister1
daytwister1 Aug. 20 at 5:06 PM
$ABCL Ca n we close even ? :) i try fishing now 11,56
1 · Reply
Bullock3000
Bullock3000 Aug. 20 at 4:55 PM
$ABCL Nobody is shorting common shares. It's still at 22% float, where it has been forever. So, this is an organic move which has been going on the past 2 weeks. The daily pump candles is all that has been keeping this up. If they stop ...
1 · Reply
Bullock3000
Bullock3000 Aug. 20 at 4:43 PM
$ABCL I see a green candle. Is the pump phase still on?
0 · Reply
Bazziggr
Bazziggr Aug. 20 at 4:40 PM
$ABCL profit taking
0 · Reply
Bullock3000
Bullock3000 Aug. 20 at 4:40 PM
$ABCL If the dump has started, this name will be worth more to insiders at $6 than $12. It is the same company it was on August 6th less a dilution and a Faux Phase 2 announcement that did ot address ADAs or immunogenicity.
0 · Reply
Bullock3000
Bullock3000 Aug. 20 at 4:37 PM
$ABCL If the insiders are still PUMPING the stock we will see big green candles today. If they have initiated the DUMPING stage, watch out below. This stock is a vehicle just like $OPEN and $GRRR. The insiders profit during the coordinated pump and the dump.
0 · Reply
hellomynameiz
hellomynameiz Aug. 20 at 4:24 PM
$ABCL bulls must have menopause they get so emotional when you tell them this stock is not worth what it’s being traded at
1 · Reply
torfel86
torfel86 Aug. 20 at 4:15 PM
$ABCL q pasa hoy?
0 · Reply
Latest News on ABCL
AbCellera announces $200M common stock, warrants offering

2026-08-11T20:05:47.000Z - 8 days ago

AbCellera announces $200M common stock, warrants offering


AbCellera price target raised to $30 from $12 at Truist

2026-08-11T13:35:37.000Z - 9 days ago

AbCellera price target raised to $30 from $12 at Truist


AbCellera Biologics Slides: Corporate presentation

Aug 10, 2026, 8:00 AM EDT - 10 days ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Study result

Aug 10, 2026, 7:30 AM EDT - 10 days ago

AbCellera Biologics Transcript: Study result


AbCellera Biologics Press release: Study result

Aug 10, 2026, 7:30 AM EDT - 10 days ago

AbCellera Biologics Press release: Study result


AbCellera Biologics Slides: Study result

Aug 10, 2026, 7:30 AM EDT - 10 days ago

AbCellera Biologics Slides: Study result


AbCellera price target raised to $9 from $8 at Stifel

2026-08-06T12:20:50.000Z - 14 days ago

AbCellera price target raised to $9 from $8 at Stifel


AbCellera Biologics Earnings Call Transcript: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Earnings Call Transcript: Q2 2026


AbCellera Biologics Slides: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Slides: Q2 2026


AbCellera Biologics Earnings release: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Earnings release: Q2 2026


AbCellera Biologics Quarterly report: Q2 2026

Aug 5, 2026, 5:00 PM EDT - 14 days ago

AbCellera Biologics Quarterly report: Q2 2026


AbCellera Reports Q2 2026 Business Results

Aug 5, 2026, 4:05 PM EDT - 14 days ago

AbCellera Reports Q2 2026 Business Results


AbCellera upgraded to Buy from Hold at Benchmark

2026-07-07T10:35:14.000Z - 6 weeks ago

AbCellera upgraded to Buy from Hold at Benchmark

JAZZ


AbCellera apponts Lynn Seely to board of directors

2026-07-06T13:15:29.000Z - 6 weeks ago

AbCellera apponts Lynn Seely to board of directors

LYEL


AbCellera Appoints Dr. Lynn Seely to its Board of Directors

Jul 6, 2026, 9:00 AM EDT - 6 weeks ago

AbCellera Appoints Dr. Lynn Seely to its Board of Directors


AbCellera Appoints Dr. Victor Sandor to its Board of Directors

Jun 5, 2026, 9:00 AM EDT - 2 months ago

AbCellera Appoints Dr. Victor Sandor to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 3 months ago

AbCellera Biologics Slides: Q1 2026


AbCellera Biologics Slides: Corporate presentation

May 1, 2026, 8:00 AM EDT - 3 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 6 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 7 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference

Nov 13, 2025, 8:00 AM EST - 10 months ago

AbCellera Biologics Transcript: Stifel 2025 Healthcare Conference


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 10 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 10 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 10 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 1 year ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


snowPOW
snowPOW Aug. 20 at 5:52 PM
$BB what I'm watching in relation to this old news for the upcoming summit https://www.pm.gc.ca/en/news/news-releases/2026/04/17/prime-minister-carney-announces-first-ever-canada-investment-summit $TSAT and $ABCL too Obviously there's many more, but these are the ones on my radar.
0 · Reply
Bullock3000
Bullock3000 Aug. 20 at 5:18 PM
$ABCL Cute chart, saw it onn X last night. What the chart doesn't address is immunogenicity. For BLA products, our bodies form new antibodies to destroy the BLA product. Each dose of the BLA adds immunogenicity. That's why the duration of efficacy for a BLA is months, not years, as in small molecules.
1 · Reply
daytwister1
daytwister1 Aug. 20 at 5:06 PM
$ABCL Ca n we close even ? :) i try fishing now 11,56
1 · Reply
Bullock3000
Bullock3000 Aug. 20 at 4:55 PM
$ABCL Nobody is shorting common shares. It's still at 22% float, where it has been forever. So, this is an organic move which has been going on the past 2 weeks. The daily pump candles is all that has been keeping this up. If they stop ...
1 · Reply
Bullock3000
Bullock3000 Aug. 20 at 4:43 PM
$ABCL I see a green candle. Is the pump phase still on?
0 · Reply
Bazziggr
Bazziggr Aug. 20 at 4:40 PM
$ABCL profit taking
0 · Reply
Bullock3000
Bullock3000 Aug. 20 at 4:40 PM
$ABCL If the dump has started, this name will be worth more to insiders at $6 than $12. It is the same company it was on August 6th less a dilution and a Faux Phase 2 announcement that did ot address ADAs or immunogenicity.
0 · Reply
Bullock3000
Bullock3000 Aug. 20 at 4:37 PM
$ABCL If the insiders are still PUMPING the stock we will see big green candles today. If they have initiated the DUMPING stage, watch out below. This stock is a vehicle just like $OPEN and $GRRR. The insiders profit during the coordinated pump and the dump.
0 · Reply
hellomynameiz
hellomynameiz Aug. 20 at 4:24 PM
$ABCL bulls must have menopause they get so emotional when you tell them this stock is not worth what it’s being traded at
1 · Reply
torfel86
torfel86 Aug. 20 at 4:15 PM
$ABCL q pasa hoy?
0 · Reply
hellomynameiz
hellomynameiz Aug. 20 at 2:52 PM
$ABCL I honestly was hoping this went over 12 so I can add onto my shorts
3 · Reply
lustiger
lustiger Aug. 20 at 1:39 PM
$ABCL red, green, red, green, red, bit like traffic lights today...
0 · Reply
Instwr
Instwr Aug. 20 at 1:36 PM
$ABCL 13+ today lets go!
0 · Reply
lustiger
lustiger Aug. 20 at 1:29 PM
$ABCL green after 10 minutes.
1 · Reply
hellomynameiz
hellomynameiz Aug. 20 at 12:26 PM
1 · Reply
NN555
NN555 Aug. 20 at 11:36 AM
0 · Reply
Planetpaprika
Planetpaprika Aug. 20 at 10:37 AM
$ABCL The (so called) analysts have a consensus price target of $14.62 for AbCellera Biologics based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $30.0, and the most bearish reporting a price target of just $7.0. Result: Fair Value of $14.63 (UNDERVALUED). https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abcl/abcellera-biologics/news/abcellera-biologics-abcl-reports-phase-2-success-is-it-still AbCellera has drawn renewed investor attention following encouraging PH 2 clinical data from one of its internal programs, alongside a substantial cash position. It is referenced to illustrate the scale, capabilities, and recent momentum of an established antibody-discovery platform, a much larger and better-capitalized company than MindWalk f.e., whose progress helps define the competitive landscape MindWalk operates within...
1 · Reply
FreyBentos
FreyBentos Aug. 20 at 9:33 AM
$ABCL Back in the green after 5 years of red lol
2 · Reply
Stockholde
Stockholde Aug. 20 at 4:38 AM
$ABCL cant believe how much money i have made on this and it keeps going up wven more damn tjank uou god and thank you carl! Lets goo
0 · Reply
NowWeKnow
NowWeKnow Aug. 20 at 1:08 AM
$ABCL Waiting for our Morderna moment
0 · Reply
healthcareguru
healthcareguru Aug. 20 at 1:01 AM
$ABCL clown show…worth $5 max. 👎
2 · Reply
Plan2TradeTrade2Plan
Plan2TradeTrade2Plan Aug. 19 at 10:32 PM
did $ABCL kill the AbCellera-$MRNA partnership from 2021, or is it still active?
3 · Reply